| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 4 May 2026 | 28 Apr 2026 |
| Wockhardt Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/05/2026 inter alia to consider and approve We wish to inform you that a meeting of the Board of Directors of the Company will be held on Monday 4th May 2026 inter-alia to consider and approve the following: (i) the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and financial year ended 31st March 2026; and (ii) raising of funds by issue of Equity Shares Equity Shares through depository receipt including Global Depository Receipts American Depository Receipts Foreign Currency Convertible Bonds Fully Convertible Debentures Partly Convertible Debentures OCD and /or NCD and/ or other securities convertible into Equity Shares with or without warrants and/ or convertible preference shares or any security convertible into Equity Shares or any combination of such securities in one or more tranches by way of one or more public and/ or private offerings including QIP and/or on preferential allotment basis or any combination thereof or any other method as may be permitted. Pursuant to Regulation 30 and 33 of Listing Regulations read with Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations ); and in continuation to our letter bearing reference no. Ref. No.: WOCK/SEC/SE/2026-27/006 dated 28th April, 2026, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 4th May, 2026, inter-alia, has approved:i. the Audited Financial Results and Financial Statements (Standalone & Consolidated) for the quarter and financial year ended 31st March, 2026. Kindly find enclosed herewith:a. Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended 31st March, 2026 along with Audit Report issued by M/s. M S K C & Associates LLP, Statutory Auditors of the Company on the same (enclosed as Annexure I); and b. Declaration on unmodified opinion on Audit Report (enclosed as Annexure II) ii Enabling proposal for raising of funds by issue of equity shares / securities convertible into equity shares/ non-convertible securities or any combination thereof in one or more tranches of public and/or private offerings, Qualified Institutions Placement and/or on preferential allotment basis or any combination thereof or any other method as may be permitted under applicable law, subject to consent of the shareholders at the ensuing Annual General Meeting and such approvals and compliances as may be required. (As Per NSE Announcement Dated On : 04.05.2026) | ||
| Board Meeting | 10 Feb 2026 | 4 Feb 2026 |
| Wockhardt Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (LODR) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 10th February 2026 inter alia to consider and approve the Un-audited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended 31st December 2025. Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015; and in continuation to our letter bearing reference no: WOCK/SEC/SE/2025-26/065 dated 4th February, 2026, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 10th February,2026, inter-alia, has approve the Un-Audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December, 2025; (As Per BSE Announcement Dated on:10.02.2026) | ||
| Board Meeting | 3 Nov 2025 | 29 Oct 2025 |
| Wockhardt Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2025 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Monday 3rd November 2025 inter- alia to consider and approve the Un-audited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended 30th September 2025. Pursuant to Regulation 30 of SEBI *LODR), Regulation 2015 please find attached herewith un-audited financial results (standalone and consolited) for the quarter and half year ended 30th September 2025 (As Per BSE Announcement Dated on: 03.11.2025) | ||
| Board Meeting | 8 Aug 2025 | 1 Aug 2025 |
| Wockhardt Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (LODR) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Friday 8th August 2025 inter- alia to consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30th June 2025. Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 (Listing Regulations) and in continuation to our letter bearing reference no.: WOCK/SEC/SE/2025-26/026 dated 1st August, 2025 we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 8th August, 2025, inter-alia, has approved the Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2025 (As per BSE Announcement Dated on 08/08/2025) | ||
| Board Meeting | 29 May 2025 | 23 May 2025 |
| Wockhardt Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve (1)The Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and financial year ended 31st March 2025; & 2) Raising of funds as mentioned in the attached intimation. Pursuant to SEBI Listing Regulations, 2015, Please find enclosed herewith the Outcome of the Board Meeting held today i.e. 29th May, 2025, along with the Audited Standalone and Consolidated financial results for the quarter and year ended 31st March, 2025. Pursuant to Regulation 30 of SEBI Listing Regulations, 2015, Please find enclosed herewith the Outcome of the Board Meeting held today, i.e. 29th May, 2025 along with the Audited Standalone and Consolidated Financial Results. Pursuant to Regulation 30 of SEBI Listing Regulation, 2015, Please find enclosed herewith disclosure in respect of 1) Re-appointment of Mr. Akhilesh Krishna Gupta, Independent Director; and 2) Appointment of Mr. Virendra G. Bhatt as Secretarial Auditor of the Company. (As Per BSE Announcement Dated on 29.05.2025) | ||
WCK 6777 is the only once-a-day antibiotic in the global pipeline designated for outpatient parenteral antimicrobial therapy (OPAT).
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
